Pathophysiologic significance of B-cell clusters in chronically rejected grafts

Transplantation

Volumn 92, Issue 2, 2011, Pages 121-126

  Thaunat, Olivier ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

Author keywords

Alloantibody; Anti HLA antibody; B cells; Chronic rejection; Lymphoid neogenesis; Tertiary lymphoid organs; Tolerance; Transplantation

Indexed keywords

HLA ANTIBODY;

ALLOTRANSPLANTATION; ANTIBODY SPECIFICITY; B CELL CLUSTER; B LYMPHOCYTE; BIOPSY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CYTOKINE PRODUCTION; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; LYMPHANGIOGENESIS; LYMPHOID TISSUE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; BIOPSY; GRAFT REJECTION; HUMANS; LYMPHOID TISSUE; MODELS, BIOLOGICAL; ORGAN TRANSPLANTATION;

EID: 79960290459     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821f74fe     Document Type: Review

References (65)

1. Motallebzadeh R, Bolton EM, Pettigrew GJ. Lymphoid tissue formation in allografts: Innocent until proven guilty. Transplantation 2008; 85: 309.
2. Jeannet M, Pinn VW, Flax MH, et al. Humoral antibodies in renal allotransplantation in man. NEngl J Med 1970; 282: 111.
3. Russell PS, Chase CM, Colvin RB. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997; 64: 1531.
4. Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol 2005; 17:541.
5. Duquesnoy RJ. Clinical use fulness of HLA Matchmaker in HLA epitope matching for organtrans plantation. Curr Opin Immunol2008; 20:594.
6. Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation 2008; 86: 1019.
7. Opelz G. Non-HLA transplantation immunity revealed by lymphocy-totoxic antibodies. Lancet2005; 365: 1570.
8. Porcheray F, De Vito J, Yeap BY, et al. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 2010; 89: 1239.
9. Zhang Q, Reed EF. Non-MHC antigenic targets of the humoral im-mune response in transplantation. Curr Opin Immunol 2010; 22: 682.
10. Li L, Wadia P, Chen R, et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 2009; 106: 4148.
11. Hidalgo LG, Campbell PM, Sis B, et al. De novo donor-specific anti-body at the time ofkidney transplant biopsy associates with microvas-cular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
12. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome ofsubclinical antibody-mediated rejection in kidney transplant recipients with pre-formed donor-specific antibodies. Am J Transplant2009; 9: 2561.
13. Arnold ML, Zacher T, Dechant M, et al. Detection and specification of noncomplement binding anti-HLA alloantibodies. Hum Immunol 2004; 65: 1288.
14. Koka P, Chia D, Terasaki PI, et al. The role of Ig A anti-HLA class I antibodies in kidneytransplant survival. Transplantation 1993; 56:207.
15. Li F, Atz ME, Reed EF. Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways. Curr Opin Immunol2009; 21: 557.
16. Thaunat O, Louedec L, Dai J, et al. Direct and indirect effects ofalloan-tibodies link neointimal and medial remodeling in graft arteriosclero-sis. Arterioscler Thromb Vasc Biol 2006; 26: 2359.
17. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807.
18. Drayton DL, Liao S, Mounzer RH, et al. Lymphoid organ development: From ontogeny to neogenesis. Nat Immunol 2006; 7: 344.
19. Baddoura FK, Nasr IW, Wrobel B, et al. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005; 5:510.
20. Thaunat O, Field AC, Dai J, et al. Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA2005; 102: 14723.
21. Kerjaschki D, Regele HM,Moosberger I,etal.Lymphaticneoangiogen-esis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. JAm Soc Nephrol 2004; 15: 603.
22. Sato M, Hirayama S, Hwang DM, et al. The role ofintrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplan-tation. JImmunol 2009; 182: 7307.
23. Di Carlo E, D'Antuono T, Contento S, et al. Quilty effect has the fea-tures of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections. Am J Transplant 2007; 7: 201.
24. Thaunat O, Patey N, Morelon E, et al. Lymphoid neogenesis in chronic rejection: The murderer is in the house. Curr Opin Immunol 2006; 18:576.
25. Wehner JR, Fox-Talbot K, Halushka MK, et al. B cells and plasma cells in coronaries of chronically rejected cardiac transplants. Transplanta-tion 2010; 89: 1141.
26. Thaunat O, Patey N, Caligiuri G, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through re-capitulation of lymphoid organogenesis. JImmunol 2010; 185: 717.
27. Deteix C, Attuil-Audenis V, Duthey A, et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010; 184:5344.
28. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol 2006; 27: 441.
29. Thaunat O, Graff-Dubois S, Brouard S, et al. Immune responses elic-ited in tertiary lymphoid tissues display distinctive features. PLo S One 2010; 5: e11398.
30. Joshi A, Masek MA, Brown BW Jr, et al. "Quilty" revisited: A 10-year perspective. Hum Pathol 1995; 26: 547.
31. Thaunat O, Legendre C, Morelon E, et al. To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? Transplantation 2007; 84: 671.
32. Yamani MH, Ratliff NB, Starling RC, et al. Quilty lesions are associated with increased expression of vitronectin receptor (alphavbeta3) and subsequent development of coronary vasculopathy. J Heart Lung Transplant 2003; 22: 687.
33. Chu KE, Ho EK, de la Torre L, et al. The relationship ofnodular endo-cardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplanta-tion. Cardiovasc Pathol 2005; 14:219.
34. Hiemann NE, Knosalla C, Wellnhofer E, et al. Quilty indicates in-creased risk for microvasculopathy and poor survival after heart trans-plantation. JHeart Lung Transplant 2008; 27: 289.
35. Zakliczynski M, Nozynski J, Konecka-Mrowka D, et al. Quilty effect correlates with biopsy-proven acute cellular rejection but does not pre-dict transplanted heart coronary artery vasculopathy. J Heart Lung Transplant 2009; 28: 255.
36. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. NEngl JMed 2003; 349: 125.
37. + infil-trates with poorer clinical outcomes in acute cellular rejection ofrenal allografts. Am J Transplant 2005; 5: 2248.
38. Kayler LK, Lakkis FG, Morgan C, et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients follow-ing lymphocyte depletion. Am J Transplant 2007; 7: 949.
39. Bagnasco SM, Tsai W, Rahman MH, et al. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant 2007; 7: 1968.
40. Scheepstra C, Bemelman FJ, van der Loos C, et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome ofrenal allo-graft rejection. Transplantation 2008; 86: 772.
41. Martin L, Charon-Barra C, Bocrie O, et al. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies ofrenal transplant recipients with chronic dysfunction. Transpl Immunol 2010; 22: 110.
42. + B cells in renal allograft. Transplantation 2010;89: 1489.
43. Einecke G, Reeve J, Mengel M, et al. Expression of B cell and immuno-globulin transcripts is a feature of inflammation in late allografts. Am J Transplant 2008;8: 1434.
44. Anglicheau D, Suthanthiran M. Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 2008; 86: 192.
45. Colvin RB, Hirohashi T, Farris AB, et al. Emerging role of B cells in chronic allograft dysfunction. Kidney Int 2010; 78(suppl 119): S13.
46. Tarlinton DM, Batista F, Smith KG. The B-cell response to protein antigens in immunity and transplantation. Transplantation 2008; 85: 1698.
47. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008; 74: 664.
48. Nasr IW, Reel M, Oberbarnscheidt MH, et al. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am JTransplant 2007; 7: 1071.
49. Iijima N, Linehan MM, Zamora M, et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. JExp Med 2008; 205: 3041.
50. Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development ofmemory CD4 cells. J Immunol 2000; 165: 5558.
51. Lund FE, Randall TD. Effector and regulatory B cells: Modulators of CD4(+) Tcellimmunity. Nat Rev Immunol 2010; 10:236.
52. Wojciechowski W, Harris DP, Sprague F, et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 2009; 30:421.
53. Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators ofautoimmune pathology. Nat Rev Immunol 2008; 8: 391.
54. Thaunat O, Morelon E, Defrance T. Am"B"valent: Anti-CD20 anti-bodies unravel the dual role of B cells in immunopathogenesis. Blood 2010; 116:515.
55. Fillatreau S, Sweenie CH, Mc Geachy MJ, et al. B cells regulate autoim-munity by provision of IL-10. Nat Immunol 2002; 3: 944.
56. Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008; 118: 3420.
57. Mauri C, Gray D, Mushtaq N, et al. Prevention of arthritis by interleu-kin 10-producing B cells.JExp Med 2003; 197: 489.
58. Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007; 178: 6092.
59. Blair PA, Norena LY, Flores-Borja F, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are function-ally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32: 129.
60. Clatworthy MR, Watson CJ, Plotnek G, et al. B-cell-depleting induction the rapy and acute cell ularrejection. NEngl J Med 2009; 360: 2683.
61. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836.
62. Pallier A, Hillion S, Danger R, et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010; 78: 503.
63. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. JClin Invest 2010; 120: 1848.
64. Brown K, Sacks SH, Wong W. Tertiary lymphoid organs in renal allo-grafts can be associated with donor-specific tolerance rather than re-jection. Eur J Immunol2011; 41:89.
65. Le Texier L, Thebault P, Lavault A, et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011; 11: 429.